Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Apexigen Inc.
DescriptionHumanized mAb against receptor activator of NF-kappa B ligand (RANKL; TNFSF11)
Molecular Target Receptor activator of NF-kappa B ligand (RANKL) (TNFSF11)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today